Mirum Pharmaceuticals, Inc. (MIRM)
64.43
-1.29
(-1.96%)
USD |
NASDAQ |
Dec 12, 12:43
Mirum Pharmaceuticals Cash from Investing (Quarterly): -2.227M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | -25.25M |
| Insmed, Inc. | -762.23M |
| CorMedix, Inc. | -291.32M |
| ADMA Biologics, Inc. | -14.37M |
| Stoke Therapeutics, Inc. | 9.094M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 39.68M |
| Cash from Financing (Quarterly) | 16.10M |
| Free Cash Flow | 44.32M |
| Free Cash Flow Per Share (Quarterly) | 0.693 |
| Free Cash Flow to Equity (Quarterly) | 39.63M |
| Free Cash Flow to Firm (Quarterly) | 43.46M |
| Free Cash Flow Yield | 1.35% |